Biohaven Ltd.
BHVN
$8.23
-$0.14-1.67%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -738.82M | -780.11M | -766.97M | -888.60M | -846.42M |
| Total Depreciation and Amortization | 9.92M | 9.81M | 8.68M | 8.66M | 7.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 118.11M | 115.62M | 84.52M | 248.17M | 239.30M |
| Change in Net Operating Assets | 1.36M | 5.17M | 28.70M | -13.17M | 16.81M |
| Cash from Operations | -609.44M | -649.52M | -645.08M | -644.94M | -582.45M |
| Capital Expenditure | -715.00K | -756.00K | -1.35M | -4.07M | -4.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 391.00K | 391.00K | 0.00 | 391.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 301.28M | 226.99M | -30.78M | -110.06M | -241.32M |
| Cash from Investing | 300.56M | 226.62M | -31.74M | -114.13M | -244.97M |
| Total Debt Issued | 250.00M | 250.00M | 250.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 191.01M | 275.77M | 356.02M | 675.83M | 677.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.89M | -2.60M | -2.60M | -1.11M | 108.00K |
| Cash from Financing | 439.12M | 523.17M | 603.43M | 674.72M | 677.77M |
| Foreign Exchange rate Adjustments | -3.00K | 85.00K | 71.00K | 104.00K | 75.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.24M | 100.37M | -73.32M | -84.24M | -149.58M |